HWBK
HAWTHORN BANCSHARES Closes FSC Bancshares Deal, Assets Reach $2.2B
The Missouri bank holding company completed its acquisition of Farmers State Bank parent FSC Bancshares on September 3, lifting total assets to about $2.2 billion.
REDFILED Newsdesk
News from SEC filings, FDA decisions and company releases, drafted with AI and checked by an editor before publication. How we work: redfiled.com/how-we-work/
HURC
HURCO Returns to Profit as Orders Jump 25% in Fiscal Q3
The CNC machine tool maker earned $0.35 a share against a year-ago loss, with gross margin up 800 basis points to 28% and orders up 24% year to date.
ZS
ZSCALER Posts 25% Q4 Revenue Growth, Guides FY27 to 17%
Fourth-quarter revenue rose 25% to $898.2 million and ARR reached $3.77 billion, but Zscaler's fiscal 2027 outlook implies a sharp slowdown.
BBCP
CONCRETE PUMPING Starts $0.13 Dividend and Lifts FY26 Outlook
Q3 revenue rose 13% to $116.8 million, guidance was raised again, and the board approved a first-ever quarterly dividend yielding about 5.6%.
LULU
LULULEMON Cuts Full-Year Outlook as Comparable Sales Fall 9%
Q2 revenue slipped 4% to $2.4 billion and lululemon now sees full-year revenue declining 5% to 7%, with Q3 sales set to drop as much as 11%.
ARBK
ARGO BLOCKCHAIN CEO Justin Nolan Departs With $250,000 Payout
Argo Blockchain says Justin Nolan ceased to be CEO effective August 30, 2026, and has begun a search for a permanent successor with AI infrastructure experience.
GURE
GULF RESOURCES Files 8-K on Nasdaq Listing Deficiency
The Shandong-based chemicals producer disclosed an Item 3.01 notice covering delisting or failure to satisfy a continued listing rule.
TAK
TAKEDA Terminates Phase 3 Soticlestat Study in Dravet and Lennox-Gastaut
Takeda has halted a Phase 3 trial of soticlestat in epilepsy patients previously exposed to fenfluramine, citing a business decision unrelated to patient safety.
QNCX
QUINCE THERAPEUTICS Files 8-K Flagging Listing Rule Issue
The biotech filed an Item 3.01 disclosure with the SEC covering a delisting notice or failure to meet a continued listing standard, dated August 31, 2026.
PDEX
PRO-DEX Posts 17% Q4 Sales Growth as Gross Margin Jumps to 35%
The surgical device maker reported fiscal 2026 net sales of $77.5 million and full-year diluted EPS of $4.12, helped by its largest customer's next-generation handpiece.
TMUS
T-MOBILE Names Ex-Shell CFO Jessica Uhl as Osvaldik Heads for Retirement
Jessica Uhl joins T-Mobile as CFO Designate in mid-September and takes over from Peter Osvaldik in February 2027; 2026 guidance reaffirmed.
LTGO
LATIGO Posts First Results Since $397M IPO, Phase 3 Set for Late 2026
Latigo Biotherapeutics reported a $25.8 million second-quarter loss and said IPO proceeds fund operations into 2029 as onzotrigine heads to Phase 3.